Table 1. Clinical characteristics of hospitalised control patients without COVID-19 on admission and nonsevere and severe patients with confirmed COVID-19 on admission.
Reference ranges of PT, aPTT, Fibrinogen, and D-Dimer are shown in parentheses. Results are presented as mean ± SD.
| Hospitalised Controls (n = 20) | Nonsevere COVID-19 (n = 20) | Severe COVID-19 (n = 34) | p-value | |
|---|---|---|---|---|
| Age (years) | 64.2 ± 17.9 | 69.25 ± 17.7 | 59.4 ± 10.5 | 0.066 |
| Male, n (%) | 10 (50%) | 13 (65%) | 21 (62%) | 0.682 |
| PCT (%) | 0.262 ± 0.11 | 0.246 ± 0.10 | N/A | 0.626 |
| P-LCR (%) | 25.40 ± 9.34 | 23.43 ± 7.57 | N/A | 0.47 |
| PT (s) (10.4–13.0) | 13.56 ± 6.92 | 13.26 ± 2.02 | 13.87 ± 5.47 | 0.886 |
| aPTT (s) (25.0–36.5) | 28.84 ± 14.17 | 29.22 ± 1.99 | 33.08 ± 8.35 | 0.272 |
| Fibrinogen (g/L) (1.5–4.0) | 5.46 ± 1.72 | 4.65 ± 1.64 | 5.58 ± 1.74 | 0.544 |
| D-Dimer (mg/L) (0.0–0.5) | 2.53 ± 1.62 | 1.01 ± 0.75 | 4.95 ± 6.36 | 0.027 |
aPTT, activated partial thromboplastin time; COVID-19, Coronavirus Disease 2019; PCT, plateletcrit; PLCR, platelet-large cell ratio; PT, prothrombin time.